الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

vanda pharmaceuticals netherlands b.v. - tasimelteon - søvnforstyrrelser, sirkadisk rytme - psykoleptiske - hetlioz er indisert for behandling av ikke-24-timers sove-våkne lidelse (non-24) i helt blind voksne.

النرويج - النرويجية - Statens legemiddelverk

bioq pharma b.v. - ropivakainhydrokloridmonohydrat - infusjonsvæske, oppløsning i administreringssystem - 2 mg/ ml

الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

astrazeneca ab - acalabrutinib - leukemi, lymfocytisk, kronisk, b-celle - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.

النرويج - النرويجية - Statens legemiddelverk

medical valley invest ab - duloksetinhydroklorid - enterokapsel, hard - 60 mg

النرويج - النرويجية - Statens legemiddelverk

medical valley invest ab - duloksetinhydroklorid - enterokapsel, hard - 30 mg

النرويج - النرويجية - Statens legemiddelverk

aristo pharma gmbh - duloksetinhydroklorid - enterokapsel, hard - 60 mg

النرويج - النرويجية - Statens legemiddelverk

aristo pharma gmbh - duloksetinhydroklorid - enterokapsel, hard - 30 mg

الاتحاد الأوروبي - النرويجية - EMA (European Medicines Agency)

axunio pharma gmbh - pirfenidone - idiopatisk lungefibrose - immunsuppressive - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).

النرويج - النرويجية - Statens legemiddelverk

sandoz - københavn - pirfenidon - tablett, filmdrasjert - 801 mg

النرويج - النرويجية - Statens legemiddelverk

sandoz - københavn - pirfenidon - tablett, filmdrasjert - 267 mg